G-protein coupled receptor assays: To measure affinity or efficacy that is the question

Combinatorial Chemistry and High Throughput Screening

Volumn 8, Issue 4, 2005, Pages 285-292

  Williams, C ^a   Sewing, A ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Affinity; Assay development; Cell based; Cells; Efficacy; Function; G protein coupled receptors; High throughput screening

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

ARTICLE; AUTOMATION; CELL ASSAY; DEVICE; DRUG INDUSTRY; GENETIC ENGINEERING; HIGH THROUGHPUT SCREENING; PRIORITY JOURNAL;

ANIMALS; AUTOMATION; BIOLOGICAL ASSAY; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; RECEPTORS, G-PROTEIN-COUPLED; SENSITIVITY AND SPECIFICITY;

EID: 18844370417     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/1386207054020778     Document Type: Article

References (52)

1. Sittampalam, G.; Kahl, S.D.; Janzen, W.P. Curr. Opin. Chem. Biol., 1997, 1, 384.
2. Hoffman, C.; Leitz, M.R.; Oberdorf-Maas, S.; Lohse, M.J.; Klotz, K.N. Naunyn-Schmeidebergs Arch. Pharmacol. 2004, 369, 151.
3. Baker, J.G.; Hall, I.P.; Hill, S.J. Mol. Pharmacol., 2004, 65, 986.
4. Mertens, I.; Vandingenen, A.; Meeusen, T.; De Loof, A.; Schoofs, L. Pharmacogenomics, 2004, 5, 657.
5. Wise, A.; Jupe, S.C.; Rees, S.; Annu. Rev. Pharmacol. Toxicol., 2004, 44, 43.
6. Christopoulos, A. Nature Rev. Drug Discov., 2002, 1, 198.
7. Kenakin, T. Molecular Interventions, 2004, 4, 222.
8. Litschig, S.; Gasparini, F.; Rueegg, D.; Stoehr, N.; Flor, P.J.; Vranesic, I.; Prezeau, L.; Pin, J-P.; Thomsen, C.; Kuhn, R. Mol. Pharmacol., 1999, 55, 453.
9. van Straten, N.C.R.; Schoonus-Gerritsma, G.G.; van Someren, R.G.; Draaijer, J.; Adang, A.E.P.; Timmers, C.M.; Hanssen, R.G.J.M.; van Boeckel, C.A.A. ChemBioChem, 2002, 10, 1023.
10. Moore, K. and Rees, S. J. Biomol. Screen., 2001, 6, 69.
11. Milligan, G. Trends. Pharmacol. Sci., 2003, 24, 87.
12. Frang, H.; Mukkala, V.M.; Syysto, R.; Ollikka, P.; Hurskainen, P.; Scheinin, M.; Hemmila, I. Assay Drug Dev. Technol., 2003, 1, 275.
13. Horstman, D.A.; Takemura, H.; Putney, J.W. Jr. (1988) J. Biol. Chem., 1988, 263, 15297.
14. Chambers, C.; Smith, F.; Gribbon, P.; Marcos, S.; Liu, Z.H.; Hayter, P.; Williams, C.; Ciaramella, G.; Keighley, W.; Sewing, A. Combinatorial Chemistry & Highthroughput Screening, 2003, 6, 355.
15. Schroeder, K.S.; and Neagle, B.D. J. Biomol. Screen., 1996, 1, 75.
16. Williams, C. Nature Rev. Drug Discov., 2004, 3, 125.
17. Hill, S.J.; Baker, J.G.; Rees, S. Curr. Opin. Pharmacol., 2001, 1, 526.
18. Wood, K.V. Curr. Opin. Biotech., 1995, 6, 50.
19. Conway, B.R.; Minor, L.K.; Xu, S.Z.; Gunnel, J.W.; DeBiasio, R.; D'Andrea, M.R.; Rubin, R.; DeBiasio, R.; Giuliano, K.; DeBiasio, L.; Demarest, K.T., J. Biomol. Screen., 1999, 4, 75.
20. Adie, E.J.; Francis, M.J.; Davis, J.; Smith, L.; Marenghi, A.; Hather, C.; Hadingham, K.; Michael, N.P.; Milligan, G.; Game, S. Assay Drug Dev. Technol., 2003, 1, 251.
21. Oakley, R.H.; Hudson, C.C.; Cruishank, R.D.; Meyers, D.M.; Payne, R.E. Jr.; Rhen, S.M.; Loomis, C.R. Assay Drug Dev. Technol., 2002, 1, 21.
22. Milligan, G.; and Rees, S. Trends Pharmacol Sci., 1999, 20, 118.
23. Kostenis, E. Trends Pharmacol Sci., 2001, 22, 560.
24. Zlokarnik, G.; Negulescu, P.A.; Knapp, T.E.; Mere, L.; Burres, N.; Feng, L.; Whitney, M.; Roemer, K.; Tsien, R.Y. Science, 1998, 279, 84.
25. Knapp, T.; Hare, E.; Feng, L.; Zlokarnik, G.; Negulescu, P. Cytometry, 2003, 51, 68.
26. Whitney, M.; Rockenstein, E.; Cantin, G.; Knapp, T.; Zlokarnik, G.; Sanders, P.; Durick, K.; Craig, F.F.; Negulescu, P.A. Nature Biotechnol., 1998, 16, 1329.
27. Allen, M.; Hall, D.; Collins, B.; Moore, K. J. Biomol. Screen., 2002, 7, 35.
28. Golla, R.; Seethala, R. J. Biomol. Screen., 2002, 7, 515.
29. Goetz, A.S.; Andrews, J.L.; Littleton, T.R.; Ignar, D.M. J. Biomol. Screen, 2000, 5, 377.
30. Bradley, J.; Gill, J.; Bertelli, F.; Letafat, S.; Corbau, R.; Hayter, P.; Harrison, P.; Tee, A.; Keighley, W.; Perros, M.; Ciaramella, G.; Sewing A.; Williams, C. J. Biomol. Screen., 2004, 9, 516.
31. DeLapp, N.W. TIPS, 2004, 25, 400.
32. George, S, E.; Bungay, P.J.; Naylor, L.H. J. Biomol. Screen. 1997, 2, 235.
33. Pagliaro, L.; Praestegaard, M. J. Biomol. Screen., 2001, 6, 133.
34. Cheng, Y.C.; Prusoff, W.H. Biochem. Pharmacol., 1973, 22, 3099.
35. Craig, D. Trends Pharmacol. Sci., 1993, 14, 89.
36. Leff, P. and Dougall, G. Trends Pharmacol. Sci., 1993, 14, 110.
37. Christopoulos, A.; Parsons, A.M.; Lew, M.J.; El-Fakahany E.E. Eur. J. Pharmacol., 1999, 382, 217.
38. Sakamoto, A.; Yanagisawa, M.; Tsujimoto, G.; Nakao, K.; Toyooka, T.; and Masaki, T. Biochem. Biophys. Res. Comm., 1994, 200, 679.
39. rd ed., Lippincott-Raven: Philadelphia, 1997.
40. Niedernberg, A.; Tunaru, S.; Blaukat, A.; Harris, B.; Kostenis, E. J. Biomol. Screen., 2003, 8, 500.
41. Chen, G.; Way, J.; Armour, S.; Watson, C.; Queen, C.; Jayawickreme, C.K.; Chen, W-J.; Kenakin, T., Mol. Pharmacol., 2000, 75, 125.
42. Kemp, D.M.; George, S.E.; Bungay, P.J.; Naylor, L.H. Eur. J. Pharmacol., 1999, 373, 215.
43. Terstappen, G.C.; Giacometti, A.; Ballini, E.; Aldegheri, L. J. Biomol. Screen., 2000, 5, 255.
44. Morisset, s.; Rouleau, A.; Ligneau, X.; Gbahou, F.; Tardivel-Lacombe, J.; Stark, H.; Schunak, W.; Ganellin, C.R.; Schwartz, J-C.; Arrang, J-M. Nature, 2000, 408, 860.
45. Zhang, J-H.; Chung, T.D.Y.; Oldenburg, K.R. J. Biomol. Screen., 1999, 4, 67.
46. Gribbon, P. and Sewing, A. Drug Discov. Today, 2003, 8, 1035.
47. Goetz, A.S.; Liacos, J.; Yingling, J.; Ignar, D.M., J. Pharmacol. Toxicol. Methods, 1999, 42, 225.
48. Beske, O.; Guo, J.; Li, J.; Bassoni, D.; Bland, K.; Marciniak, H.; Zarowitz, M.; Temov, V.; Ravkin, I.; Goldbard, S. J. Biomol. Screen., 2004, 9, 173.
49. Hopkins, A.L. and Groom, C.R. Nature Rev. Drug Disc., 2002, 1, 727.
50. Booth, B. and Zemmel, R. Nature Rev. Drug Disc., 2004, 3, 451.
51. Bleicher, K.H.; Bohm, H.J.; Muller, K.; Alanine, A.I. Nature Rev. Drug Discov., 2003, 2, 369.
52. Walters, W.P. and Namchuk, M. Nat. Rev. Drug Discov., 2003, 2, 259.